Search
for
Sort by
Research 241–270 of 1000+
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- Penatalaksanaan Alopecia Areata (Treatment of Allopecia Areata)
- Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- Immune cell regulation of the hair cycle
- The concealed side of caspases: beyond a killer of cells
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics
- Valproic acid boosts hair follicle stem cell resilience to oxygen-glucose deprivation through autophagy induction and AKT/mTOR suppression
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Abstracts
- Management of congenital ichthyoses: European guidelines of care, part two
- 219 STAT5 activation in the dermal papilla is important for hair follicle growth phase induction, hair follicle regeneration and wound healing
- 218 Chemokine receptor CCR5 is the novel target for the treatment of alopecia areata
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation.
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Localization of Plasminogen Activator Inhibitor Type 2 (PAI-2) in Hair and Nail: Implications for Terminal Differentiation
- Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Inflammatory Cytokine TNFα Promotes the Long-Term Expansion of Primary Hepatocytes in 3D Culture
- Injury-induced interleukin-1 alpha promotes Lgr5 hair follicle stem cells de novo regeneration and proliferation via regulating regenerative microenvironment in mice
- Diabetes Mellitus Inhibits Hair Follicle Regeneration by Inducing Macrophage Reprogramming-Mediated Pyroptosis